Zobrazeno 1 - 2
of 2
pro vyhledávání: '"Intan Hamid"'
Autor:
Ian Judson, Marco Maruzzo, Gerard M Walls, Charlotte Benson, Aisha Miah, Komel Khabra, Omar Al-Muderis, Shane Zaidi, Nicos Fotiadis, Robin L. Jones, Simon Jordan, Intan Hamid
Publikováno v:
Walls, G M, Zaidi, S H, Fotiadis, N, Jordan, S, Maruzzo, M, Hamid, I, Al-Muderis, O, Khabra, K, Benson, C, Jones, R L, Judson, I R & Miah, A B 2021, ' Treatments and Outcomes in Oligometastatic Soft Tissue Soft Sarcoma-A Single Centre Retrospective Analysis ', Anticancer research, vol. 41, no. 10, pp. 5089-5096 . https://doi.org/10.21873/anticanres.15325
Background/aim Distinguishing true oligometastatic disease from early polymetastatic disease is vital in patients with soft tissue sarcoma as contemporary treatment strategies differ significantly. Clinical factors such as tumour biology, organ invol
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::85a1f2f8c6bad9537870b062a68fa05b
https://pubmed.ncbi.nlm.nih.gov/34593459
https://pubmed.ncbi.nlm.nih.gov/34593459
Autor:
Sara Reis, Intan Hamid, Sophie McGrath, Susannah Stanway, Alicia Okines, Jaishree Bhosle, Vasileios Angelis, Marco Gerlinger, Heba Soliman, Zayd Tippu, Firza Gronthoud, Robin L. Jones, Emma Cottier, Charlotte Fribbens, Jillian Noble, David Watkins, Spyridon Gennatas, Kroopa Joshi, Pablo Nenclares, Kevin J. Harrington
Publikováno v:
European Journal of Cancer
Background In light of the coronavirus disease 2019 (COVID-19) pandemic, cancer centres in the United Kingdom and Europe re-organised their services at an unprecedented pace, and many patients with cancer have had their treatments severely disrupted.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::91aad53019149f6eb9da70a9c6e547a5
http://europepmc.org/articles/PMC7340059
http://europepmc.org/articles/PMC7340059